BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34790017)

  • 1. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study.
    Shousha HI; Afify S; Maher R; Asem N; Fouad E; Mostafa EF; Medhat MA; Abdalazeem A; Elmorsy H; Aziz MM; Mohammed RS; Ibrahem M; Elgarem H; Omran D; Hassany M; Elsayed B; Abdelaziz AY; El Kassas M
    World J Gastroenterol; 2021 Oct; 27(40):6951-6966. PubMed ID: 34790017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
    Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
    Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
    Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
    Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus disease 19 (Covid-19): A comparative study of pattern of liver injury in adult patients in different waves of Covid-19 infection.
    Abdellatif Z; Abdel-Haleem H; Abdalaziz RA; Ramadan A; Al-Sharif AM; El-Korashy RIM; Soliman YMA; Hussein SA; Kamal MM; Abdullatif MMA; AbdelRazik MM; Eldessouky NMT; Atef M
    Arab J Gastroenterol; 2024 May; 25(2):170-175. PubMed ID: 38378355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study.
    Madian A; Eliwa A; Abdalla H; Aly HAA
    World J Hepatol; 2021 Aug; 13(8):939-948. PubMed ID: 34552700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease.
    Higuera-de-la-Tijera F; Servín-Caamaño A; Reyes-Herrera D; Flores-López A; Robiou-Vivero EJA; Martínez-Rivera F; Galindo-Hernández V; Rosales-Salyano VH; Casillas-Suárez C; Chapa-Azuela O; Chávez-Morales A; Jiménez-Bobadilla B; Hernández-Medel ML; Orozco-Zúñiga B; Zacarías-Ezzat JR; Camacho S; Pérez-Hernández JL
    Dis Markers; 2021; 2021():6658270. PubMed ID: 33791045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and risk factors for death in patients with coronavirus disease-2019 (COVID-19) pneumonia admitted to the intensive care units of an Egyptian University Hospital. A retrospective cohort study.
    Nassar Y; Mokhtar A; Elhadidy A; Elsayed M; Mostafa F; Rady A; Eladawy A; Elshazly M; Saeed M; Mokhtar S; Buschbeck S; Sakr Y
    J Infect Public Health; 2021 Oct; 14(10):1381-1388. PubMed ID: 34215561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Biochemistries in Hospitalized Patients With COVID-19.
    Bloom PP; Meyerowitz EA; Reinus Z; Daidone M; Gustafson J; Kim AY; Schaefer E; Chung RT
    Hepatology; 2021 Mar; 73(3):890-900. PubMed ID: 32415860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
    Sharma A; Jaiswal P; Kerakhan Y; Saravanan L; Murtaza Z; Zergham A; Honganur NS; Akbar A; Deol A; Francis B; Patel S; Mehta D; Jaiswal R; Singh J; Patel U; Malik P
    Ann Hepatol; 2021; 21():100273. PubMed ID: 33075578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
    Frager SZ; Szymanski J; Schwartz JM; Massoumi HS; Kinkhabwala M; Wolkoff AW
    Hepatol Commun; 2021 Mar; 5(3):424-433. PubMed ID: 33681677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Manifestations of Coronavirus Disease 2019 Across the United States: A Multicenter Cohort Study.
    Patel AP; Sanders TK; Prakash P; Law J; Alvencar S; Choi A; Shah J; Patel K; Srivoleti P; Chauhan K; Weissman S; Holzwanger E; Dhingra R; Nguyen M; Kim D; Sidhu T; Stallwood C; Dickstein A; Parekh N; Altayar O; Ciorba MA; Yu J; Chen LA; Tabibian JH; Limketkai BN
    Gastro Hep Adv; 2022; 1(6):909-915. PubMed ID: 35874930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Xiang F; Sun J; Chen PH; Han P; Zheng H; Cai S; Kirk GD
    Clin Infect Dis; 2021 Aug; 73(3):e594-e601. PubMed ID: 33909004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study.
    Minata M; Harada KH; Yamaguchi T; Fujitani T; Nakagawa H
    Diabetes Ther; 2022 Dec; 13(11-12):1847-1860. PubMed ID: 36136238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver dysfunction and clinical outcomes of unvaccinated COVID-19 patients with and without chronic hepatitis B.
    Chang HC; Su TH; Huang YT; Hong CM; Sheng WH; Hsueh PR; Kao JH
    J Microbiol Immunol Infect; 2024 Feb; 57(1):55-63. PubMed ID: 38110321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
    Wang Q; Zhao H; Liu LG; Wang YB; Zhang T; Li MH; Xu YL; Gao GJ; Xiong HF; Fan Y; Cao Y; Ding R; Wang JJ; Cheng C; Xie W
    Mil Med Res; 2020 Jun; 7(1):28. PubMed ID: 32507110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.